UrnovF. Genome Editing B.C. (Before CRISPR): Lasting lessons from the “Old Testament. Crispr J, 2018; 1(1):34–46.
2.
PorteusMH, BaltimoreD. Chimeric nucleases stimulate gene targeting in human cells. Science, 2003; 300(5620):763.
3.
CarrollD. Genome engineering with zinc-finger nucleases. Genetics, 2011; 188(4):773–782.
4.
UrnovFD, MillerJC, LeeY-L, et al.Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature, 2005; 435(7042):646–651.
5.
OrkinSH, BauerDE. Emerging genetic therapy for sickle cell disease. Annu Rev Med, 2019; 70:257–271.
6.
PlattOS, BrambillaDJ, RosseWF, et al.Mortality in sickle cell disease—Life expectancy and risk factors for early death. New Engl J Med, 1994; 330:1639–1644.
7.
GrayV, ThomasU, DaviesK. Warrior spirit: An interview with Victoria Gray, sickle cell pioneer. Crispr J, 2024; 7(1):5–11.
